Literature DB >> 12749012

Health status and health-related quality of life associated with von Willebrand disease.

Ronald D Barr1, Julia Sek, John Horsman, William Furlong, Mahassen Saleh, Mohan Pai, Irwin Walker.   

Abstract

Von Willebrand disease (VWD) is the commonest inherited disorder of hemostasis and the majority of women with this disorder experience excessive uterine bleeding. Yet very little information is available on the health-related quality of life (HRQL) in individuals with VWD. To test the a priori hypotheses that these individuals will have poorer HRQL than members of the general population, and that this burden of morbidity will correlate with the severity of VWD, a cross-sectional study was undertaken of a population-based cohort in a regional hemophilia program in Ontario, Canada. A survey was made of individuals over 13 years of age with VWD who self-reported their health status using a standard 15 item questionnaire. The responses were converted to levels in the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3) health status classification systems to form multi-element vectors from which single attribute morbidity and overall HRQL utility scores were determined. As a group, individuals with VWD were shown to have poorer HRQL than members of the general population and those with Type 2 disease carried a greater burden of overall morbidity than those with Type 1 disorder. Morbidity was evident mainly in the attributes of emotion, cognition with pain. A striking difference was observed between males and females, with the latter having overall HRQL utility scores similar to those reported previously for HIV positive, severe hemophiliacs. It is possible that this remarkable burden of morbidity reflects chronic iron deficiency associated with menorrhagia. A national study has been proposed to address this likelihood as it offers an opportunity for effective therapeutic intervention (iron supplementation) with a concomitant gain in health status and HRQL. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12749012     DOI: 10.1002/ajh.10327

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

Review 1.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

2.  Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

Authors:  C Rae; W Furlong; J Horsman; E Pullenayegum; C Demers; J St-Louis; D Lillicrap; R Barr
Journal:  Haemophilia       Date:  2012-09-21       Impact factor: 4.287

3.  Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease.

Authors:  Igor Govorov; Lena Ekelund; Roza Chaireti; Petra Elfvinge; Margareta Holmström; Katarina Bremme; Miriam Mints
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

4.  Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.

Authors:  V R Byams; P A Kouides; R Kulkarni; J R Baker; D L Brown; J C Gill; A M Grant; A H James; B A Konkle; J Maahs; M M Dumas; S McAlister; D Nance; D Nugent; C S Philipp; J M Soucie; E Stang
Journal:  Haemophilia       Date:  2011-07       Impact factor: 4.287

Review 5.  A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations.

Authors:  Gang Chen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

6.  Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Authors:  N Rydz; J Grabell; D Lillicrap; P D James
Journal:  Haemophilia       Date:  2015-03-10       Impact factor: 4.287

7.  Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database.

Authors:  Jonathan C Roberts; Lynn M Malec; Imrran Halari; Sarah A Hale; Abiola Oladapo; Robert F Sidonio
Journal:  Haemophilia       Date:  2021-11-10       Impact factor: 4.263

8.  Gender differences in health-related quality of life of adolescents with cystic fibrosis.

Authors:  Renata Arrington-Sanders; Michael S Yi; Joel Tsevat; Robert W Wilmott; Joseph M Mrus; Maria T Britto
Journal:  Health Qual Life Outcomes       Date:  2006-01-24       Impact factor: 3.186

9.  Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study).

Authors:  Guenter Auerswald; Claudia Djambas Khayat; Oleksandra Stasyshyn; Genadi Iosava; Irina Romashevskaya; Marta Julia López; Wilfried Seifert; Tobias Rogosch
Journal:  J Blood Med       Date:  2020-06-22

10.  Diagnostic value of saline infusion sonohysterography for detecting endometrial focal lesion.

Authors:  Sanam Moradan; Sati Nik Darzi; Raheb Ghorbani
Journal:  Pan Afr Med J       Date:  2019-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.